Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds
暂无分享,去创建一个
[1] Franco Lombardo,et al. In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set. , 2009, Journal of medicinal chemistry.
[2] S Oie,et al. Effect of altered plasma protein binding on apparent volume of distribution. , 1979, Journal of pharmaceutical sciences.
[3] D J Rance,et al. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. , 1997, The Journal of pharmacology and experimental therapeutics.
[4] Michael Mayersohn,et al. A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry. , 2006, Journal of pharmaceutical sciences.
[5] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[6] Keith W Ward,et al. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[7] R J Riley,et al. The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions. , 2006, Current drug metabolism.
[8] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[9] Malcolm Rowland,et al. Incorporating measures of variability and uncertainty into the prediction of in vivo hepatic clearance from in vitro data. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[10] M Paul Gleeson,et al. Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis. , 2007, Journal of medicinal chemistry.
[11] Taravat Ghafourian,et al. QSPR models for the prediction of apparent volume of distribution. , 2006, International journal of pharmaceutics.
[12] Dennis A. Smith. Physicochemical Properties in Drug Metabolism and Pharmacokinetics , 2007 .
[13] Franco Lombardo,et al. A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human. , 2006, Journal of medicinal chemistry.
[14] Ulf Norinder,et al. Prediction of ADMET Properties , 2006, ChemMedChem.
[15] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[16] Keith W Ward,et al. Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. , 2005, Journal of pharmaceutical sciences.
[17] Sitarama B. Gunturi,et al. In Silico ADME Modeling 3: Computational Models to Predict Human Intestinal Absorption Using Sphere Exclusion and kNN QSAR Methods , 2007 .
[18] Franco Lombardo,et al. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. , 2004, Journal of medicinal chemistry.
[19] J. Kremer,et al. Drug binding to human alpha-1-acid glycoprotein in health and disease. , 1988, Pharmacological reviews.
[20] M Paul Gleeson,et al. In silico human and rat Vss quantitative structure-activity relationship models. , 2006, Journal of medicinal chemistry.
[21] Gary W. Caldwell,et al. Allometric scaling of pharmacokinetic parameters in drug discovery: Can human CL, Vss and t1/2 be predicted fromin-vivo rat data? , 2004, European Journal of Drug Metabolism and Pharmacokinetics.
[22] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[23] Christopher A Evans,et al. EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS , 2006, Drug Metabolism and Disposition.
[24] Franco Lombardo,et al. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. , 2002, Journal of medicinal chemistry.
[25] R J Riley,et al. Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs. , 2007, Current drug metabolism.
[26] U. Fagerholm,et al. Prediction of human pharmacokinetics – evaluation of methods for prediction of volume of distribution , 2007, The Journal of pharmacy and pharmacology.
[27] G. Cruciani,et al. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. , 2005, Journal of medicinal chemistry.
[28] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[29] I Mahmood,et al. Interspecies allometric scaling: prediction of clearance in large animal species: part II: mathematical considerations. , 2006, Journal of veterinary pharmacology and therapeutics.
[30] Han van de Waterbeemd,et al. Lipophilicity in PK design: methyl, ethyl, futile , 2001, J. Comput. Aided Mol. Des..
[31] I Mahmood,et al. Interspecies allometric scaling. Part I: prediction of clearance in large animals. , 2006, Journal of veterinary pharmacology and therapeutics.
[32] R. Austin,et al. A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES , 2005, Drug Metabolism and Disposition.
[33] David F. V. Lewis,et al. Baseline Lipophilicity Relationships in Human Cytochromes P450 Associated with Drug Metabolism , 2003, Drug metabolism reviews.
[34] Z H Israili,et al. HUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡ , 2001, Drug metabolism reviews.
[35] Keith W Ward,et al. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[36] P. Sluijs,et al. The influence of binding to albumin and α1-acid glycoprotein on the clearance of drugs by the liver , 1987, Pharmaceutisch Weekblad.
[37] W. Daniel,et al. Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. , 1997, Pharmacology & toxicology.
[38] S. Curry,et al. Structural basis of the drug-binding specificity of human serum albumin. , 2005, Journal of molecular biology.